Should I Buy MLAB Stock in 2026?

Data-driven analysis and honest assessment for Mesa Laboratories Inc

Analysis Updated:
CAUTIONSeveral concerns warrant careful consideration

Current Price: $87.07P/E: 136.0

Decision Score

4.3/10

Weak

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)2/10

Very high P/E of 136.0 suggests overvaluation

Growth (20%)3/10

Declining -0%

Profitability (20%)4/10

Thin margins (0% net)

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)8/10

Strong FCF yield of 6.1%

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$87.07

P/E Ratio

136.05

Revenue Growth

0.0%

Profit Margin

0.0%

Market Cap

$0.5B

Dividend Yield

0.01%

How MLAB Compares to Competitors

Understanding how MLAB stacks up against peers helps inform your investment decision.

How MLAB Compares to Peers

Upcoming Events for MLAB

+5 Reasons TO Buy MLAB

1. High gross margins of 62%

moderate

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

2. High free cash flow yield of 6.1%

moderate

FCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.

-5 Reasons NOT to Buy MLAB

1. Expensive valuation at 136x earnings

high risk

P/E of 136 is significantly above averages. High expectations leave little room for disappointment.

2. Thin profit margins of 0.0%

high risk

Low margins provide little cushion against cost increases or pricing pressure.

3. Small-cap volatility risk

high risk

Market cap under $2B means higher volatility and lower liquidity.

4. Minimal revenue growth

low risk

Growth of 0.0% barely keeps pace with inflation.

Who Should Buy MLAB?

Investment Profile

Risk Level

Very High

Recommended Holding Period

3-5 years

Best For:

  • Momentum Traders

    High-growth profile attracts momentum

Not Suitable For:

  • Growth Investors

    Limited 0% growth may disappoint

  • Value Investors

    Premium P/E of 136 doesn't fit value criteria

  • Income-Focused Retirees

    Low 0.0% yield

  • Risk-Averse Investors

    Very High risk may cause uncomfortable volatility

Consider These Alternatives

If you're interested in MLAB, compare these Health Care peers:

Pro tip: Compare MLAB directly with competitors using our comparison tool to see which stock better fits your criteria.

Get the Full Picture

Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for MLAB

Frequently Asked Questions

What is MLAB stock price today?

MLAB (Mesa Laboratories Inc) stock is trading at $87.07 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MLAB stock going up or down today?

MLAB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MLAB stock now?

The decision to buy MLAB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MLAB a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MLAB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MLAB stock overvalued or undervalued?

MLAB currently trades at a P/E ratio of 136.05, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if MLAB is fairly priced.

What is MLAB's P/E ratio?

MLAB has a price-to-earnings (P/E) ratio of 136.05, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is MLAB's market cap?

MLAB (Mesa Laboratories Inc) has a market capitalization of $0.48 billion, making it a small-cap stock.

What is MLAB's price to book ratio?

MLAB trades at a price-to-book (P/B) ratio of 2.75, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Similar Investment Decisions

Explore investment analyses for stocks similar to Mesa Laboratories Inc

Explore Categories

Disclaimer

This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.